Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is an increasingly recognized disorder associated with high mortality rates. The pathomechanisms of CUA are only partially understood ...
Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...
The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback